Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ganaxolone for use in treating tuberous sclerosis complex

Ganaxolone for use in treating tuberous sclerosis complex

US Patent 11701367 · Granted Jul 18, 2023

Estimated economic value: $8,376,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2024